RANDOMISED CONTROLLED TRIALS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) - A SYSTEMATIC REVIEW (SR) OF INCLUDED PATIENT POPULATIONS

被引：0
|
作者：
Ahuja, A. [1 ]
Agrawal, R. [2 ]
Thakur, L. [2 ]
Natani, H. [2 ]
Cristino, J. [3 ]
Croft, D. [4 ]
Gielen, V [4 ]
机构：
[1] Novartis Healthcare Pvt Ltd, Chandigarh, India
[2] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India
[3] Novartis Pharma AG, Basel, Switzerland
[4] Novartis Pharmaceut Ltd, Frimley, Surrey, England
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.557
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV10
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [1] Reporting trends of randomised controlled trials in heart failure with preserved ejection fraction: a systematic review
    Zheng, Sean L.
    Chan, Fiona T.
    Maclean, Edd
    Jayakumar, Shruti
    Nabeebaccus, Adam A.
    [J]. OPEN HEART, 2016, 3 (02):
  • [2] Heart failure with preserved ejection fraction (HFpEF)
    Maeder, Micha T.
    Buser, Marc
    Brenner, Roman
    Rickli, Hans
    [J]. THERAPEUTISCHE UMSCHAU, 2018, 75 (03) : 161 - 169
  • [3] Hospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF): a systematic review
    Hannah Clark
    Rezwanul Rana
    Jeff Gow
    Melissa Pearson
    Tom van der Touw
    Neil Smart
    [J]. Heart Failure Reviews, 2022, 27 : 559 - 572
  • [4] Hospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF): a systematic review
    Clark, Hannah
    Rana, Rezwanul
    Gow, Jeff
    Pearson, Melissa
    van der Touw, Tom
    Smart, Neil
    [J]. HEART FAILURE REVIEWS, 2022, 27 (02) : 559 - 572
  • [5] Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review
    Lekavich, Carolyn L.
    Barksdale, Debra J.
    Neelon, Virginia
    Wu, Jia-Rong
    [J]. HEART FAILURE REVIEWS, 2015, 20 (06) : 643 - 653
  • [6] Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review
    Carolyn L. Lekavich
    Debra J. Barksdale
    Virginia Neelon
    Jia-Rong Wu
    [J]. Heart Failure Reviews, 2015, 20 : 643 - 653
  • [7] Quality of life (QoL) in patients with heart failure with preserved ejection fraction (HFpEF): a systematic review
    Chen, J.
    Hunt, P.
    Khordoc, C.
    Hardy, E.
    Mitchell, C.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 780 - 780
  • [8] heart failure with preserved ejection fraction(HFpEF) in elderly
    Sinha, A. K.
    Sinha, A.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 92 - 92
  • [9] PREDICTORS OF HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)
    Kumar, A.
    Saluja, A. K.
    Khan, A.
    Gandhi, D.
    Morsy, M. A.
    Khalife, W. I.
    [J]. CARDIOLOGY, 2014, 128 : 467 - 468
  • [10] Heart peptides and HFpEF (heart failure with preserved ejection fraction)
    Takahashi, Kazuhiro
    [J]. PEPTIDES, 2022, 157
12345